Characteristics of samples used in this study (means ± SD). by Sergiy G. Gychka (13175728)

Cytosolic mitochondrial DNA release upon MeV and MeV-ΔV infection in culture and in mice. by Pierre Khalfi (7868252)

Effect of 5-HTR blockade on cost-based motivation. by Yukiko Hori (299784)

PKC inhibition increases intracellular cAMP and PKC activation decreases intracellular cAMP levels. by Katie M. Lowther (427408)

HFD modulates survival rate by decreasing parasite load in the hearts of infected mice during acute infection (n = 15). by Fnu Nagajyothi (37087)

“…(<b>b</b>) qPCR analysis demonstrates a significant decrease (5 fold) of parasites in the hearts of HFD fed infected mice compared to the infected RD fed mice. …”

As₂O₃ decreases myoblast growth. by Shing Hwa Liu (38213)

Downhill Running-Based Overtraining Protocol Improves Hepatic Insulin Signaling Pathway without Concomitant Decrease of Inflammatory Proteins - Fig 5 by Alisson L. da Rocha (804331)

Spinal cord of CCI-mice treated with EGCG and compound 30 at 14 dpi showed decreased levels of inflammatory cytokines by Xavier Xifró (719821)

Chemical inhibition of formins decreases actin pedestal assembly by EPEC, but not by KC12+EspF_U. by Katrina B. Velle (4330957)

Fig 5 - by Wardah K. Mustahsan (17484456)

CPZ decreases K⁺-dependent Na⁺, K⁺-ATPase transport activity. by Yasser A. Mahmmoud (562155)

Inhibition of ERK 1/2 decreases GM-CSF- and IL-3-responsive Eo/B CFU, but not IL-5-responsive colonies. by Pia Reece (589971)

Focal adhesion kinase phosphorylation levels within the optic nerve head decrease steadily after intraocular pressure elevation. by Shandiz Tehrani (3365900)

Hepatic irradiation decreases the proportion of DX5^–TRAIL⁺ lrNK cells for up to two months. by Ryosuke Nakano (4557097)

“…NK cells were divided into DX5^–TRAIL⁺ lrNK cells and DX5⁺TRAIL⁻ cNK cells. …”

Developmental delay of <i>rpS13/+</i> animals is not due to a decrease in ribosome numbers or reduced translation rates. by Lisa Patricia Deliu (13570709)

Pharmacologic blockade of 5LO decreases Aβ peptides levels and deposition in the 3×Tg mice via the γ-secretase pathway. by Jin Chu (358006)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

Subjects: